個人簡介：

Jeff He is the Co-Founder & CEO at TandemAI. He brings 20+ year leadership experience in corporate strategy, business development, venture financing and operation.

Previously, Jeff co-founded HiFiBiO Therapeutics and served as its Chief Operating Officer since 2017. Prior to that, Jeff was co-founder & CFO at Harbour BioMed from 2015 to 2017. Before launching his entrepreneurial career, Jeff served as Executive Vice President of Strategy and Operation at ShangPharma/ChemPartner for 3 years. Mr. He also served as Senior Vice President at Texas Pacific Group (TPG), where he helped to privatize ShangPharma from the NYSE. Prior to TPG, Mr. He held management roles with increasing P&L responsibilities at Danaher/Fluke and Saint-Gobain. In his early career, he was a strategy consultant at Bain & Company and a senior financial analyst at Intel.

Mr. He received his MBA degree from Goizueta Business School at Emory University, M.S. degree in Economics from Shanghai Univ. of Science and Technology, and bachelor degree in engineering from Zhejiang University.

公司簡介：

TandemAI是一家先進的技術公司，致力于降低進入藥物發現領域最先進工具的門檻。我們的集成藥物發現平臺結合了一套專有的人工智能和基于物理的藥物發現工具、定制的超級計算基礎設施和大規模濕實驗室操作，使藥物發現中最先進工具的訪問民主化，并提升研究人員的體驗。?

TandemAI的科學家協作團隊與全球科學界合作，大幅提高臨床前候選藥物的成功率，并最終幫助改善等待新治療方案的患者的生活。

TandemAI目前的重點是幫助客戶推進臨床前小分子候選藥物。我們的愿景是與客戶一起成長，以支持他們在生物制劑和其他大分子療法方面的發現工作。